---
figid: PMC10814963__cancers-16-00470-g004
figtitle: Proposed model for Fyn-CD133 signaling to the PI3K pathway induces melanoma
  intrinsic and acquired resistance to anti-cancer agent in melanoma cells
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC10814963
filename: PMC10814963__cancers-16-00470-g004.jpg
figlink: /pmc/articles/PMC10814963/figure/F4
number: F4
caption: 'A proposed model for Fyn-CD133 signaling to the PI3K pathway induces melanoma
  intrinsic and acquired resistance to anti-cancer agent in melanoma cells. (A) Fyn
  stimulated CD133 signaling to the PI3K pathway in melanoma population bearing the
  BRAF wild type (BRAFWT) is mediated by Fyn/CD133/PI3K/PDK1/AKT-induced inhibition
  of p27, Fyn/CD133/PI3K/AKT/MDM2-induced ubiquitination of p53 and Fyn/CD133/Grb2/Grb7/NRAS7BRAF/MEK/ERK-induced
  cell growth. (B) Intrinsic resistance of melanoma cells: Fyn stimulated CD133 signaling
  to the Grb2/Grb7/NRAS7BRAF/MEK/ERK pathway is responsible for acquired resistance
  of BRAF inhibitors (e.g., dabrafenib)'
papertitle: 'Mechanisms of Melanoma Progression and Treatment Resistance: Role of
  Cancer Stem-like Cells'
reftext: Youssef Al Hmada, et al. Cancers (Basel). 2024 Jan;16(2).
year: '2024'
doi: 10.3390/cancers16020470
journal_title: Cancers
journal_nlm_ta: Cancers (Basel)
publisher_name: MDPI
keywords: melanoma | CSCs | PI3K | MAPK | BRAF
automl_pathway: 0.8898222
figid_alias: PMC10814963__F4
figtype: Figure
redirect_from: /figures/PMC10814963__F4
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC10814963__cancers-16-00470-g004.html
  '@type': Dataset
  description: 'A proposed model for Fyn-CD133 signaling to the PI3K pathway induces
    melanoma intrinsic and acquired resistance to anti-cancer agent in melanoma cells.
    (A) Fyn stimulated CD133 signaling to the PI3K pathway in melanoma population
    bearing the BRAF wild type (BRAFWT) is mediated by Fyn/CD133/PI3K/PDK1/AKT-induced
    inhibition of p27, Fyn/CD133/PI3K/AKT/MDM2-induced ubiquitination of p53 and Fyn/CD133/Grb2/Grb7/NRAS7BRAF/MEK/ERK-induced
    cell growth. (B) Intrinsic resistance of melanoma cells: Fyn stimulated CD133
    signaling to the Grb2/Grb7/NRAS7BRAF/MEK/ERK pathway is responsible for acquired
    resistance of BRAF inhibitors (e.g., dabrafenib)'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PROM1
  - BRAF
  - MMUT
  - SERPINA4
  - PTEN
  - PIK3R1
  - PIK3R2
  - ARHGEF7
  - CBFA2T2
  - PPP1R13B
  - PPP1R12C
  - FYN
  - GRB7
  - GRB2
  - PIK3CB
  - ETV5
  - EZR
  - RDX
  - MSN
  - TAS2R67P
  - KRAS
  - HRAS
  - NRAS
  - AKT1
  - AKT2
  - AKT3
  - RAF1
  - MDM2
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - IFI27
  - PSMD9
  - ZNRD2
  - DCTN6
  - TMED7
  - H3P23
  - TP53
  - TP63
  - TP73
  - EPHB2
  - MAPK1
  - MAPK3
  - RAS
  - MEK
---
